Nucala 00173-0904-42
Generic: Mepolizumab
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 22, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761122
Need to source Nucala? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mepolizumab | 40 mg/.4mL |
Drug Class
Interleukin-5 Antagonist [EPC]Interleukin-5 Antagonist [EPC]Interleukin-5 Antagonists [MoA]
Selected Package
00173-0904-42Selected1 SYRINGE in 1 CARTON (0173-0904-42) / .4 mL in 1 SYRINGE